Morgan Stanley Upgrades Watson Pharmaceuticals to Overweight

by Juan Lopez, Benzinga Staff Writer

January 25, 2012 6:13 AM | 8 seconds read | Make a Comment

Morgan Stanley has upgraded Watson Pharmaceuticals

WPI

from Equal-weight to Overweight and has lowered the price target from $70 to $65.

Posted In: Upgrades Price Target Pre-Market Outlook Analyst Ratings Morgan Stanley

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.